AKT1 quiescent cancer cells promote solid tumor growth
نویسندگان
چکیده
AFFILIATIONS 1 Massachusetts General Hospital Cancer Center, Boston, Massachusetts. 2 Harvard Medical School, Boston, Massachusetts. 3 Dana-Farber Cancer Institute, Boston, Massachusetts. 4 Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. 5 Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. 6 Broad Institute of Harvard & MIT, Cambridge, Massachusetts. 7 Harvard Stem Cell Institute, Cambridge, Massachusetts. 8 Harvard-Ludwig Center for Cancer Research, Boston, Massachusetts. ¶ Current address: Department of Translational Genomics, University of Cologne, Cologne, Germany. ♯ Current address: Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain. * CPA and ID-G contributed equally to the work ** Correspondence to: Sridhar Ramaswamy, Massachusetts General Hospital Cancer Center, Richard B. Simches Research Building, 185 Cambridge Street, Boston, MA 02114. E-mail: [email protected] Running title: AKT1 cancer cells are necessary for optimal solid tumor growth.
منابع مشابه
AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth.
Human tumor growth depends on rapidly dividing cancer cells driving population expansion. Even advanced tumors, however, contain slowly proliferating cancer cells for reasons that remain unclear. Here, we selectively disrupt the ability of rapidly proliferating cancer cells to spawn AKT1low daughter cells that are rare, slowly proliferating, tumor-initiating, and chemotherapy-resistant, using β...
متن کاملTwo Dimensional Mathematical Model of Tumor Angiogenesis: Coupling of Avascular Growth and Vascularization
Introduction As a tumor grows, the demand for oxygen and nutrients increases and it grows further if acquires the ability to induce angiogenesis. In this study, we aimed to present a two-dimensional continuous mathematical model for avascular tumor growth, coupled with a discrete model of angiogenesis. Materials and Methods In the avascular growth model, tumor is considered as a single mass, wh...
متن کاملTumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors.
AKT1(E17K) mutations occur at low frequency in a variety of solid tumors, including those of the breast and urinary bladder. Although this mutation has been shown to transform rodent cells in culture, it was found to be less oncogenic than PIK3CA mutations in breast epithelial cells. Moreover, the therapeutic potential of AKT inhibitors in human tumors with an endogenous AKT1(E17K) mutation is ...
متن کاملSmall Molecule Therapeutics Tumors with AKT1 Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors
AKT1mutations occur at low frequency in a variety of solid tumors, including those of the breast and urinary bladder. Although this mutation has been shown to transform rodent cells in culture, it was found to be less oncogenic than PIK3CA mutations in breast epithelial cells. Moreover, the therapeutic potential of AKT inhibitors in human tumorswith an endogenous AKT1mutation is not known. Expr...
متن کاملRole of mesenchymal stem cells in growth and progression of cancer and prospective potentials in cancer therapy
Introduction: Mesenchymal stem cells (MSCs) are present in most tissues of the body. These cells are involved in various biological processes, such as maintaining tissue homeostasis and wound healing. Recent studies have shown that tumor associated MSCs (TA-MSCs) are also present in tumor microenvironment (TME) of most solid tumors. MSCs have a strong tendency to migration toward tumor tissues....
متن کامل